BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 16103004)

  • 1. Mouse models created to study the pathophysiology of Type 2 diabetes.
    LeRoith D; Gavrilova O
    Int J Biochem Cell Biol; 2006; 38(5-6):904-12. PubMed ID: 16103004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies involving the GH-IGF axis: Lessons from IGF-I and IGF-I receptor gene targeting mouse models.
    Yakar S; Pennisi P; Kim CH; Zhao H; Toyoshima Y; Gavrilova O; LeRoith D
    J Endocrinol Invest; 2005; 28(5 Suppl):19-22. PubMed ID: 16114270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transgenic and knockout mice in diabetes research: novel insights into pathophysiology, limitations, and perspectives.
    Plum L; Wunderlich FT; Baudler S; Krone W; Brüning JC
    Physiology (Bethesda); 2005 Jun; 20():152-61. PubMed ID: 15888572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A signal for beta-cell failure.
    Avruch J
    Nature; 1998 Feb; 391(6670):846-7. PubMed ID: 9495335
    [No Abstract]   [Full Text] [Related]  

  • 5. Understanding the pathogenesis and treatment of insulin resistance and type 2 diabetes mellitus: what can we learn from transgenic and knockout mice?
    Mauvais-Jarvis F; Kahn CR
    Diabetes Metab; 2000 Dec; 26(6):433-48. PubMed ID: 11173714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Knockout mouse models for type 2 diabetes. Mice with insulin resistance].
    Terauchi Y; Kadowaki T
    Nihon Rinsho; 2002 Aug; 60 Suppl 8():64-9. PubMed ID: 12355825
    [No Abstract]   [Full Text] [Related]  

  • 7. Crucial role of insulin receptor substrate-2 in compensatory beta-cell hyperplasia in response to high fat diet-induced insulin resistance.
    Takamoto I; Terauchi Y; Kubota N; Ohsugi M; Ueki K; Kadowaki T
    Diabetes Obes Metab; 2008 Nov; 10 Suppl 4():147-56. PubMed ID: 18834442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulating insulin signaling and beta-cell function through IRS proteins.
    White MF
    Can J Physiol Pharmacol; 2006 Jul; 84(7):725-37. PubMed ID: 16998536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mouse models of insulin resistance.
    Nandi A; Kitamura Y; Kahn CR; Accili D
    Physiol Rev; 2004 Apr; 84(2):623-47. PubMed ID: 15044684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucokinase and IRS-2 are required for compensatory beta cell hyperplasia in response to high-fat diet-induced insulin resistance.
    Terauchi Y; Takamoto I; Kubota N; Matsui J; Suzuki R; Komeda K; Hara A; Toyoda Y; Miwa I; Aizawa S; Tsutsumi S; Tsubamoto Y; Hashimoto S; Eto K; Nakamura A; Noda M; Tobe K; Aburatani H; Nagai R; Kadowaki T
    J Clin Invest; 2007 Jan; 117(1):246-57. PubMed ID: 17200721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IRS2 takes center stage in the development of type 2 diabetes.
    Brady MJ
    J Clin Invest; 2004 Oct; 114(7):886-8. PubMed ID: 15467824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue-specificity of insulin action and resistance.
    Benito M
    Arch Physiol Biochem; 2011 Jul; 117(3):96-104. PubMed ID: 21506723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mouse models of insulin resistance.
    Hribal ML; Oriente F; Accili D
    Am J Physiol Endocrinol Metab; 2002 May; 282(5):E977-81. PubMed ID: 11934661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ontogenetic characteristics of enzyme activities and plasma metabolites in C57BL/6J:Jcl mice deficient in insulin receptor substrate 2.
    Hashimoto H; Arai T; Takeguchi A; Hioki K; Ohnishi Y; Kawai K; Ito M; Suzuki R; Yamauchi T; Ohsugi M; Saito M; Ueyama Y; Tobe K; Kadowaki T; Tamaoki N; Kosaka K
    Comp Med; 2006 Jun; 56(3):176-87. PubMed ID: 16774126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin resistance and pancreatic beta cell failure.
    Kasuga M
    J Clin Invest; 2006 Jul; 116(7):1756-60. PubMed ID: 16823472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fate of the beta-cell in the pathophysiology of type 2 diabetes.
    Campbell RK
    J Am Pharm Assoc (2003); 2009; 49 Suppl 1():S10-5. PubMed ID: 19801360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of islet amyloid in type 2 diabetes mellitus.
    Höppener JW; Lips CJ
    Int J Biochem Cell Biol; 2006; 38(5-6):726-36. PubMed ID: 16459127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced insulin signaling and endoplasmic reticulum stress act synergistically to deteriorate pancreatic beta cell function.
    Matsuda T; Kido Y; Uchida T; Kasuga M
    Kobe J Med Sci; 2008 Jul; 54(2):E114-21. PubMed ID: 18772613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular basis of insulin action.
    González-Sánchez JL; Serrano-Ríos M
    Drug News Perspect; 2007 Oct; 20(8):527-31. PubMed ID: 18080040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of compensatory beta-cell response in mice with combined mutations of Insr and Irs2.
    Kim JJ; Kido Y; Scherer PE; White MF; Accili D
    Am J Physiol Endocrinol Metab; 2007 Jun; 292(6):E1694-701. PubMed ID: 17299086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.